4Wirbelauer J,Thomas W,Speer CP.Preterm and term infants with a-cute respiratory distress syndrome (ARDS) ; What is the role of sur-factant sub-stitution[J].Z Geburt Shilfe Neonatol?2009,213(2):33.
5Nkadi PO,Merritt TA,Pillers DA.An overview of pulmonary surfac-tant in the neonate:Genetics,metabolism,and the role of surfactant inhealth and disease[J].Mol Genet Metab?2009,97(2):95-101.
7Colin AA,McEvoy C,Castile RG.Respiratory morbidity and lungfunction in preterm infants of 32 to 36 week's gestational age [J].Pediatrics,2010,126(1):115-128.
5Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respioatory distress in adult. Lancet, 1967,2(7511):319
6Brun-Buisson C, Minelli C, Bertolini G, et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med, 2004,30(1):51
7Neff MJ. The epiderniology and definition of acute respiratory distress syndrome. Respir Care Chin N Am, 2003,9(3):273
8Levitt JE, Matthay MA. Treatment of acute lung injury: historical perspective and potential future therapies. Semin Respir Crit Care Med, 2006, 27 (4): 426
10Karagiorga G, Nakos G, Galiatsou E, et al . Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med, 2006, 32(1):116
